| scholarly article | Q13442814 |
| P2093 | author name string | Kevin S Channer | |
| Dheeraj Kapoor | |||
| T Hugh Jones | |||
| Roger D Stanworth | |||
| P2860 | cites work | A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men | Q28275775 |
| Role of endocytosis in cellular uptake of sex steroids. | Q34448507 | ||
| Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis | Q34502187 | ||
| Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes | Q34567831 | ||
| Preclinical evaluation of lovastatin | Q39539384 | ||
| Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients | Q42482746 | ||
| Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity | Q44210279 | ||
| Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial | Q44268120 | ||
| Atorvastatin Treatment Does Not Affect Gonadal and Adrenal Hormones in Type 2 Diabetes Patients with Mild to Moderate Hypercholesterolemia | Q44621113 | ||
| The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. | Q44968760 | ||
| Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study | Q46592933 | ||
| Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes | Q46889850 | ||
| The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. | Q53820607 | ||
| Long-term therapy with high-dose simvastatin does not affect adrenocortical and gonadal hormones in hypercholesterolemic patients | Q67485962 | ||
| Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives | Q68870017 | ||
| The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolemic subjects | Q70342082 | ||
| The Apparent Free Testosterone Concentration, An Index of Androgenicity | Q70616223 | ||
| Simvastatin influences testicular steroidogenesis in human | Q72567583 | ||
| Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads | Q72614730 | ||
| Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia | Q73034904 | ||
| Validation of a screening questionnaire for androgen deficiency in aging males | Q73034907 | ||
| Sex hormone-binding globulin in endocrine regulation. (Minireview) | Q74292985 | ||
| Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations | Q81775212 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | testosterone | Q1318776 |
| type 2 diabetes | Q3025883 | ||
| testosterone | Q27863114 | ||
| statin therapy | Q62562875 | ||
| P304 | page(s) | 541-546 | |
| P577 | publication date | 2008-12-29 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes | |
| P478 | volume | 32 |
| Q39604956 | Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971]. |
| Q84596471 | Current literature in diabetes |
| Q90315384 | Diagnosis of osteoporosis in statin-treated patients is dose-dependent |
| Q37037560 | Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial |
| Q33965084 | Evaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: a pilot prospective clinical trial |
| Q37607090 | Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses |
| Q39263932 | Is testosterone important in LUT function in men and women? ICI-RS 2015. |
| Q38349680 | New horizons in testosterone and the ageing male |
| Q48271382 | Oxidative stress status in congenital hypogonadism: an appraisal. |
| Q35007603 | Statins and male sexual health: a retrospective cohort analysis |
| Q82500857 | Testosterone and cardiovascular risk in patients with erectile dysfunction |
| Q86999417 | Testosterone and insulin resistance in the metabolic syndrome and T2DM in men |
| Q35076387 | Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? |
| Q35810322 | Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review |
| Q64950572 | The Association of Serum Testosterone Levels With Recurrence and Mortality After Acute Ischemic Stroke in Males. |
| Q26999003 | The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials |
| Q34097510 | The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. |
| Q37686143 | The role of testosterone in type 2 diabetes and metabolic syndrome in men. |
| Q45921938 | Type 2 diabetes mellitus and testosterone: a meta-analysis study. |
Search more.